CorMedix CRMD Institutional Ownership

Updated Oct 11, 2026

CorMedix Inc. (NASDAQ:CRMD) had 194 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Together they owned 56.11% of the outstanding stock in Q2 2026, up from 51.77% a quarter earlier.
• Total holdings of CRMD shares rose 8.45% from Q1 2026, and the holder count rose 14.79% from Q2 2025.
• Of the 194 holders, 98 added to their positions, 60 reduced their stakes and 36 left their positions unchanged in Q2 2026.
• The aggregate institutional position in CorMedix was 44.02Mn shares at the end of Q2 2026, up 3.43Mn from the prior quarter and up 12.34Mn from a year earlier.
• As of June 30, 2026, the biggest holder of CorMedix was BlackRock, Inc. with 6.32Mn shares, or 8.06% of shares outstanding.
• The largest position increases in CRMD for Q2 2026 were by BlackRock, Inc. (+356.54K shares), UBS Group AG (+339.69K shares), HRT Financial LP (+333.11K shares), American Century Companies Inc (+318.94K shares) and Royce & Associates LP (+288.83K shares).
• Among holders that kept a stake in CorMedix, the biggest sellers in Q2 2026 were Victory Capital Management Inc (-288.18K shares), Kennedy Capital Management LLC (-254.02K shares), Lazard Asset Management LLC (-223.18K shares), Citadel Advisors LLC (-186K shares) and Palisades Investment Partners, LLC (-183.6K shares).
• Per Business Quant data, the 10 largest holders of CorMedix at the end of Q2 2026 were BlackRock, Inc. (6.32Mn shares), Deep Track Capital, LP (6.27Mn shares), Vanguard Capital Management LLC (3.14Mn shares), State Street Corp (2.32Mn shares), Royce & Associates LP (2.18Mn shares), Geode Capital Management, LLC (1.95Mn shares), UBS Group AG (1.88Mn shares), Oberweis Asset Management Inc (1.32Mn shares), Alyeska Investment Group, L.P. (850K shares) and Marshall Wace, LLP (779.53K shares).